[Memantine as an adjunctive therapy for schizophrenia negative symptoms].
Gama
Clarissa Severino
CS
Antunes
Paula
P
Moser
Carolina
C
Belmonte-de-Abreu
Paulo Silva
PS
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008559:Memantine / Q000627:therapeutic use*; D008875:Middle Aged; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D016194:Receptors, N-Methyl-D-Aspartate; D008559:Memantine